Boston, Massachusetts, Jan. 30, 2023 (GLOBE NEWSWIRE) -- #" HYCU Named to 2023 CRN Cloud 100 For fifth consecutive year, HYCU named to prestigious list for commitment to channel partners as wel...

FDA Grants U.S. Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC) 21-11-2024, 18:00